In vitro assays suggest that NK cells can exert MUC1 antibody-dependent cytotoxicity toward tumor cells [107,108], although the antitumor efficacy of ADCC has not been confirmed in vivo in cancer patients. This evidence concerns the gene MUC1 and cancer.